imaGenes GmbH Company Profile
"imaGenes is a premier provider of genome research services in Europe and was founded in 2007 as a spin-off from RZPD (German Resource Center for Genome Research). imaGenes manages one of the most comprehensive collections of clones of mammalian and vertebrate genes in the world offered via its clone search engine GenomeCube, linked to international databases. The second major research services of imaGenes features microarray services on Affymetrix, Agilent, and NimbleGen platforms for a broad range of functional analyses. imaGenes is also offering next generation sequencing services on an Illumina Genome Analyzer System."
Location
Germany
News Articles
Source BioScience plc Pre-close trading update for the six months ended 30 June 2011
July 26th 2011: Source BioScience plc (LSE: SBS, “Source BioScience”; the “Company”), the international diagnostics and genetic analysis business serving the healthcare an...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
"imaGenes is a premier provider of genome research services in Europe and was founded in 2007 as a spin-off from RZPD (German Resource Center for Genome Research). imaGenes manages one of the most com...
More Information about "imaGenes GmbH" on BioPortfolio
We have published hundreds of imaGenes GmbH news stories on BioPortfolio along with dozens of imaGenes GmbH Clinical Trials and PubMed Articles about imaGenes GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of imaGenes GmbH Companies in our database. You can also find out about relevant imaGenes GmbH Drugs and Medications on this site too.
